Urapidil as a neuroprotective agent: targeting hypoxia, inflammation, and oxidative stress in traumatic brain injury

Ahmet Bindal1, Pınar Karabacak1, Halil Asci2

  • 1Department of Anesthesiology and Reanimation, Faculty of Medicine, Suleyman Demirel University, Isparta, Türkiye.

Abstract

Insights

Urapidil (Ura) demonstrates significant neuroprotective effects against traumatic brain injury (TBI) in rats. It effectively reduces inflammation, oxidative stress, and cell death by modulating key molecular pathways, offering a promising therapeutic avenue for TBI.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Biochemistry

Background:

  • Traumatic brain injury (TBI) is a leading cause of death and disability worldwide.
  • Current pharmaceutical treatments for TBI are insufficient, necessitating novel therapeutic strategies.
  • TBI involves complex mechanisms including inflammation, oxidative stress, and apoptosis.

Purpose of the Study:

  • To investigate the neuroprotective potential of Urapidil (Ura) in a rat model of TBI.
  • To evaluate the effects of Ura on molecular signaling pathways implicated in TBI pathogenesis, including HMGB1, BNIP3L, and HIF1α.

Main Methods:

  • Thirty-two rats were allocated into control, TBI, and TBI treated with two doses of Ura (0.5 mg/kg and 5 mg/kg).
  • Assessment of tissue integrity, inflammatory markers (TNF-α), apoptosis (caspase-3), and key signaling molecules (HIF1α, BNIP3L, HMGB1).
  • Evaluation of oxidative stress markers (TOS, OSI, TAS) following Ura treatment.

Main Results:

  • Ura treatment significantly reduced histopathological damage, expressions of BNIP3L, HMGB1, HIF1α, TNF-α, caspase-3, and tyrosine hydroxylase in TBI rats.
  • Ura administration also decreased oxidative stress markers (TOS, OSI) and increased antioxidant capacity (TAS).
  • These findings indicate Ura's ability to modulate neuroinflammation, mitochondrial dysfunction, and hypoxia pathways in TBI.

Conclusions:

  • Urapidil exhibits significant tissue-protective effects in a TBI model.
  • Ura effectively targets critical pathways involved in TBI, including inflammation, oxidative stress, and apoptosis.
  • Further research into Urapidil as a therapeutic agent for TBI is warranted.

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.6K
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
54
Traumatic Brain Injury l: Introduction01:28

Traumatic Brain Injury l: Introduction

DefinitionTraumatic brain injury, or TBI, is a disturbance of normal brain function induced by an external mechanical force, such as a direct blow to the head or a penetrating injury. It can affect both brain structure and function, producing a wide range of clinical outcomes. TBI is a heterogeneous condition, meaning its effects may differ based on the type, location, and severity of the injury.Basis of ClassificationTBI is classified based on severity, injury mechanism, or pathophysiology. In...
25
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous...
20
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
53
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
52